门诊森田疗法治疗失眠症的对照研究

目的探讨门诊森田疗法辅助药物治疗失眠症的近期疗效和远期疗效。方法将60例失眠症患者随机分为研究组和对照组各30例,两组患者均口服佐匹克隆治疗,研究组辅以门诊森田疗法,于治疗前、治疗4周后及随访3个月时,分别用匹兹堡睡眠质量指数(PSQI)评定近期和远期临床效果。结果治疗4周后,研究组PSQI中6个因子分低于对照组,差异有统计学意义(t=1.98~2.76,P0.05);随访3个月时,PSQI中6个因子分低于对照组,差异有统计学意义(t=2.35~4.09,P0.05)。结论门诊森田疗法辅助药物治疗失眠症的近期效果和远期效果均优于单纯药物治疗。

Outpatient Morita Therapy in the Treatment of Insomnia

Objective To explore the short-term and long-term efficacy of outpatient Morita therapy in the treatment of insomnia . Methods 60 outpatients with insomnia were randomly assigned to study groups and control groups ,30 cases each.The study group re-ceived drug treatment and Morita therapy ,while the control group received drug treatment only for 4 weeks,then follow up 3 months.Be-fore and after 4-week treatment and follow -up 3-month,two groups were assessed with Pittsburgh Sleep Quality Index （PSQI）.Re-sults After 4-week treatment ,6 factor scores of PSQI in the study group were significantly lower than those in the control group （ t=1.98~2.76,P〈0.05 ）;Follow-up 3 months,6 factor scores of PSQI in the study group were significantly lower than those in the con-trol group（t=2.35~4.09,or P〈0.05）.Conclusion The short-term and the long -term efficacy of outpatient Morita therapy are better than those of mono -drug in the treatment of insomnia .